Waddell & Reed Financial’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-902,580
| Closed | -$21.8M | – | 490 |
|
|
2019
Q4 | $21.8M | Sell |
902,580
-977,845
| -52% | -$23.6M | 0.05% | 337 |
|
|
2019
Q3 | $36.1M | Buy |
1,880,425
+142,798
| +8% | +$2.74M | 0.09% | 238 |
|
|
2019
Q2 | $51.3M | Buy |
1,737,627
+224,655
| +15% | +$6.64M | 0.13% | 200 |
|
|
2019
Q1 | $71.9M | Buy |
1,512,972
+60,124
| +4% | +$2.86M | 0.18% | 156 |
|
|
2018
Q4 | $52.4M | Buy |
1,452,848
+743,808
| +105% | +$26.9M | 0.15% | 185 |
|
|
2018
Q3 | $43.6M | Buy |
709,040
+248,323
| +54% | +$15.3M | 0.1% | 243 |
|
|
2018
Q2 | $31.1M | Buy |
460,717
+7,170
| +2% | +$484K | 0.07% | 283 |
|
|
2018
Q1 | $24.6M | Sell |
453,547
-1,880
| -0.4% | -$102K | 0.06% | 304 |
|
|
2017
Q4 | $27.2M | Sell |
455,427
-7,927
| -2% | -$474K | 0.06% | 294 |
|
|
2017
Q3 | $22.5M | Buy |
463,354
+271,254
| +141% | +$13.2M | 0.05% | 313 |
|
|
2017
Q2 | $10.1M | Hold |
192,100
| – | – | 0.02% | 420 |
|
|
2017
Q1 | $8.71M | Hold |
192,100
| – | – | 0.02% | 447 |
|
|
2016
Q4 | $7.27M | Hold |
192,100
| – | – | 0.02% | 461 |
|
|
2016
Q3 | $7.25M | Buy |
192,100
+4,400
| +2% | +$166K | 0.02% | 444 |
|
|
2016
Q2 | $3.3M | Hold |
187,700
| – | – | 0.01% | 532 |
|
|
2016
Q1 | $2.28M | Buy |
187,700
+3,100
| +2% | +$37.7K | ﹤0.01% | 568 |
|
|
2015
Q4 | $4.5M | Hold |
184,600
| – | – | 0.01% | 500 |
|
|
2015
Q3 | $3.28M | Buy |
+184,600
| New | +$3.28M | 0.01% | 539 |
|